$SIGA
SIGA TECHNOLOGIES INC Stock $siga

$siga Overview Financials Valuation SEC Filings Company Website

2017 Form 10-K Financial Statement

#000101008618000003 Filed on March 06, 2018

Income Statement

Concept	2017	2016 Q4	2016 Q3
Revenue	$12.27M	$7.200M	$4.700M
YoY Change	-18.14%	71.43%	261.54%
Cost Of Revenue	$0.00
YoY Change
Gross Profit	$12.27M
YoY Change	-18.14%
Gross Profit Margin	100.0%
Selling, General & Admin	$12.30M	$4.464M	$2.855M
YoY Change	-10.29%	73.83%	23.01%
% of Gross Profit	100.28%
Research & Development	$16.68M	$8.158M	$6.069M
YoY Change	-15.38%	65.34%	150.06%
% of Gross Profit	135.95%
Depreciation & Amortization	$132.2K	$40.00K	$42.66K
YoY Change	-24.15%	-20.0%	-18.42%
% of Gross Profit	1.08%
Operating Expenses	$31.12M	$12.62M	$12.72M
YoY Change	-32.36%	68.25%	156.68%
Operating Profit	-$18.85M	-$6.609M	-$8.062M
YoY Change	-39.23%	-63.19%	122.15%
Interest Expense	$14.76M	-$3.100M	$94.78K
YoY Change	516.07%
% of Operating Profit
Other Income/Expense, Net	$16.79K	-$1.800M	$30.76K
YoY Change	-83.59%		146.38%
Pretax Income	-$38.33M	-$10.40M	$9.200M
YoY Change	-3.41%	-47.74%	64.29%
Income Tax	-$2.094M	$0.00	-$4.072K
% Of Pretax Income			-0.04%
Net Earnings	-$36.24M	-$10.44M	-$9.244M
YoY Change	-8.72%	-48.05%	64.16%
Net Earnings / Revenue	-295.34%	-144.99%	-196.68%
Basic Earnings Per Share	-$0.46
Diluted Earnings Per Share	-$0.46	-$157.3K	-$169.4K
COMMON SHARES
Basic Shares Outstanding	78.87M shares	54.28M shares	53.87M shares
Diluted Shares Outstanding	78.87M shares

Balance Sheet

Concept	2017	2016 Q4	2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$19.90M	$28.70M	$20.50M
YoY Change	-30.66%	-74.53%	-84.15%
Cash & Equivalents	$19.90M	$28.70M	$20.49M
Short-Term Investments
Other Short-Term Assets	$12.70M	$11.10M	$9.600M
YoY Change	14.41%	1750.0%	17.07%
Inventory	$3.000M	$26.21M	$17.75M
Prepaid Expenses
Receivables	$1.800M	$3.154M	$38.75M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$37.40M	$69.16M	$86.58M
YoY Change	-45.95%	-46.58%	-37.94%
LONG-TERM ASSETS
Property, Plant & Equipment	$100.0K	$299.5K	$330.1K
YoY Change	-66.67%	-33.42%	-27.84%
Goodwill		$898.3K	$898.3K
YoY Change		0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$106.3M	$642.1K	$642.1K
YoY Change	17.33%	-67.73%	-67.73%
Total Long-Term Assets	$107.3M	$91.82M	$76.26M
YoY Change	16.88%	63.17%	32.27%
TOTAL ASSETS
Total Short-Term Assets	$37.40M	$69.16M	$86.58M
Total Long-Term Assets	$107.3M	$91.82M	$76.26M
Total Assets	$144.7M	$161.0M	$162.8M
YoY Change	-10.12%	-13.33%	-17.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.300M	$2.517M	$2.925M
YoY Change	-48.0%	-36.19%	-7.85%
Accrued Expenses	$4.200M	$4.585M	$4.793M
YoY Change	-8.7%	35.3%	56.47%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$6.800M	$7.102M	$108.3M
YoY Change	-4.23%	-3.15%	1636.51%
LONG-TERM LIABILITIES
Long-Term Debt	$71.10M	$66.60M	$0.00
YoY Change	6.76%
Other Long-Term Liabilities	$389.9M	$374.5M	$367.4M
YoY Change	4.11%	-19.04%	-18.01%
Total Long-Term Liabilities	$461.0M	$441.1M	$367.4M
YoY Change	4.51%	-4.65%	-18.01%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.800M	$7.102M	$108.3M
Total Long-Term Liabilities	$461.0M	$441.1M	$367.4M
Total Liabilities	$467.8M	$448.4M	$476.0M
YoY Change	4.33%	-4.63%	3.07%
SHAREHOLDERS EQUITY
Retained Earnings		-$501.1M	-$490.7M
YoY Change		8.6%	11.18%
Common Stock		$213.7M	$177.5M
YoY Change		20.74%	0.48%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$323.1M	-$287.4M	-$313.2M
YoY Change
Total Liabilities & Shareholders Equity	$144.7M	$161.0M	$162.8M
YoY Change	-10.12%	-13.33%	-17.41%

Cashflow Statement

Concept	2017	2016 Q4	2016 Q3
OPERATING ACTIVITIES
Net Income	-$36.24M	-$10.44M	-$9.244M
YoY Change	-8.72%	-48.05%	64.16%
Depreciation, Depletion And Amortization	$132.2K	$40.00K	$42.66K
YoY Change	-24.15%	-20.0%	-18.42%
Cash From Operating Activities	-$18.39M	-$25.90M	-$56.23M
YoY Change	-84.26%	56.78%	-510.44%
INVESTING ACTIVITIES
Capital Expenditures	$100.1K	-$10.00K	$0.00
YoY Change	318.46%	-80.0%	-100.0%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$1.210M	$0.00
YoY Change
Cash From Investing Activities	-$100.1K	$1.200M	$0.00
YoY Change	-108.42%	-2500.0%	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$84.00K
YoY Change
Debt Paid & Issued, Net	$0.00
YoY Change
Cash From Financing Activities	-$585.6K	60.38M	-1.290M
YoY Change	-100.99%	-603900.0%
NET CHANGE
Cash From Operating Activities	-$18.39M	-25.90M	-56.23M
Cash From Investing Activities	-$100.1K	1.200M	0.000
Cash From Financing Activities	-$585.6K	60.38M	-1.290M
Net Change In Cash	-$19.07M	35.68M	-57.52M
YoY Change	-66.27%	-315.2%	-521.7%
FREE CASH FLOW
Cash From Operating Activities	-$18.39M	-$25.90M	-$56.23M
Capital Expenditures	$100.1K	-$10.00K	$0.00
Free Cash Flow	-$18.49M	-$25.89M	-$56.23M
YoY Change	-84.18%	57.19%	-508.65%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017	dei	Amendment Flag AmendmentFlag	false
CY2017	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2017	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2017	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
CY2017	dei	Document Period End Date DocumentPeriodEndDate	2017-12-31
CY2017	dei	Document Type DocumentType	10-K
CY2017	dei	Entity Central Index Key EntityCentralIndexKey	0001010086
CY2018Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	79039000	shares
CY2017	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2017	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2017Q2	dei	Entity Public Float EntityPublicFloat	239883144	USD
CY2017	dei	Entity Registrant Name EntityRegistrantName	SIGA TECHNOLOGIES INC
CY2017	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2017	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2017	dei	Trading Symbol TradingSymbol	SIGA
CY2011Q2	siga	Amountofoptiontobereceivedfrom Bard Aforapprovalforextensionof84mothexpiry AmountofoptiontobereceivedfromBARDAforapprovalforextensionof84mothexpiry	50000000	USD
CY2015	siga	Backstop Fee BackstopFee	0	USD
CY2016	siga	Backstop Fee BackstopFee	1764240	USD
CY2017	siga	Backstop Fee BackstopFee	0	USD
CY2015	siga	Change In Excess Tax Benefit Stock Based Compensation Financing Activities ChangeInExcessTaxBenefitStockBasedCompensationFinancingActivities	15531	USD
CY2016	siga	Change In Excess Tax Benefit Stock Based Compensation Financing Activities ChangeInExcessTaxBenefitStockBasedCompensationFinancingActivities	0	USD
CY2017	siga	Change In Excess Tax Benefit Stock Based Compensation Financing Activities ChangeInExcessTaxBenefitStockBasedCompensationFinancingActivities	0	USD
CY2015	siga	Collateralfor Surety Bond CollateralforSuretyBond	0	USD
CY2016	siga	Collateralfor Surety Bond CollateralforSuretyBond	1212591	USD
CY2017	siga	Collateralfor Surety Bond CollateralforSuretyBond	0	USD
CY2016Q4	siga	Computer Equipment ComputerEquipment	770479	USD
CY2017Q4	siga	Computer Equipment ComputerEquipment	701762	USD
CY2011Q2	siga	Contract Value Detail Of Option Exercisable Development Activities ContractValueDetailOfOptionExercisableDevelopmentActivities	58300000	USD
CY2011Q2	siga	Contract Value Detail Of Option Exercisable Production Activities ContractValueDetailOfOptionExercisableProductionActivities	14400000	USD
CY2011Q2	siga	Contract Value Option Fda Approval ContractValueOptionFDAApproval	50000000	USD
CY2011Q2	siga	Contract Valueof Various Options ContractValueofVariousOptions	122700000	USD
CY2016Q4	siga	Deferred Tax Liabilities Capitalized Contract Costs DeferredTaxLiabilitiesCapitalizedContractCosts	25854435	USD
CY2017Q4	siga	Deferred Tax Liabilities Capitalized Contract Costs DeferredTaxLiabilitiesCapitalizedContractCosts	21518646	USD
CY2015	siga	Effective Income Tax Rate Reconciliation Loss From Fair Value Of Common Warrants EffectiveIncomeTaxRateReconciliationLossFromFairValueOfCommonWarrants	0.000
CY2016	siga	Effective Income Tax Rate Reconciliation Loss From Fair Value Of Common Warrants EffectiveIncomeTaxRateReconciliationLossFromFairValueOfCommonWarrants	-0.008
CY2017	siga	Effective Income Tax Rate Reconciliation Loss From Fair Value Of Common Warrants EffectiveIncomeTaxRateReconciliationLossFromFairValueOfCommonWarrants	-0.043
CY2015	siga	Effective Income Tax Rate Reconciliation Loss From Reorganization Costs EffectiveIncomeTaxRateReconciliationLossFromReorganizationCosts	-0.070
CY2016	siga	Effective Income Tax Rate Reconciliation Loss From Reorganization Costs EffectiveIncomeTaxRateReconciliationLossFromReorganizationCosts	-0.033
CY2017	siga	Effective Income Tax Rate Reconciliation Loss From Reorganization Costs EffectiveIncomeTaxRateReconciliationLossFromReorganizationCosts	0.000
CY2015	siga	Income Taxes Paid Refund IncomeTaxesPaidRefund	-420029000000	USD
CY2016	siga	Income Taxes Paid Refund IncomeTaxesPaidRefund	500975000000	USD
CY2017	siga	Income Taxes Paid Refund IncomeTaxesPaidRefund	325000000000	USD
CY2015	siga	Increase In Fair Value Of Warrants IncreaseInFairValueOfWarrants	0	USD
CY2016	siga	Increase In Fair Value Of Warrants IncreaseInFairValueOfWarrants	894785	USD
CY2017	siga	Increase In Fair Value Of Warrants IncreaseInFairValueOfWarrants	4738753	USD
CY2015	siga	Interest Paidon Pharm Athene Liability InterestPaidonPharmAtheneLiability	0	USD
CY2016	siga	Interest Paidon Pharm Athene Liability InterestPaidonPharmAtheneLiability	11668900000000	USD
CY2017	siga	Interest Paidon Pharm Athene Liability InterestPaidonPharmAtheneLiability	0	USD
CY2015	siga	Interest Paidon Term Loan From Restricted Cash InterestPaidonTermLoanFromRestrictedCash	0	USD
CY2016	siga	Interest Paidon Term Loan From Restricted Cash InterestPaidonTermLoanFromRestrictedCash	1222222000000	USD
CY2017	siga	Interest Paidon Term Loan From Restricted Cash InterestPaidonTermLoanFromRestrictedCash	10288469000000	USD
CY2017	siga	Inventory Write Downs InventoryWriteDowns	686000	USD
CY2015	siga	Loss On Disposal Of Assets LossOnDisposalOfAssets	-243707	USD
CY2016	siga	Loss On Disposal Of Assets LossOnDisposalOfAssets	0	USD
CY2017	siga	Loss On Disposal Of Assets LossOnDisposalOfAssets	0	USD
CY2015	siga	Patent Preparation Fees PatentPreparationFees	1009053	USD
CY2016Q1	siga	Patent Preparation Fees PatentPreparationFees	220000	USD
CY2016Q2	siga	Patent Preparation Fees PatentPreparationFees	240000	USD
CY2016Q3	siga	Patent Preparation Fees PatentPreparationFees	230000	USD
CY2016Q4	siga	Patent Preparation Fees PatentPreparationFees	219000	USD
CY2016	siga	Patent Preparation Fees PatentPreparationFees	909376	USD
CY2017Q1	siga	Patent Preparation Fees PatentPreparationFees	241000	USD
CY2017Q2	siga	Patent Preparation Fees PatentPreparationFees	197000	USD
CY2017Q3	siga	Patent Preparation Fees PatentPreparationFees	251000	USD
CY2017Q4	siga	Patent Preparation Fees PatentPreparationFees	221000	USD
CY2017	siga	Patent Preparation Fees PatentPreparationFees	909946	USD
CY2015	siga	Paymentof Interest Expense PaymentofInterestExpense	0	USD
CY2016	siga	Paymentof Interest Expense PaymentofInterestExpense	-1222222	USD
CY2017	siga	Paymentof Interest Expense PaymentofInterestExpense	-10228469	USD
CY2015	siga	Proceedsfrom Equity Rights Offering Net ProceedsfromEquityRightsOfferingNet	0	USD
CY2016	siga	Proceedsfrom Equity Rights Offering Net ProceedsfromEquityRightsOfferingNet	34596468	USD
CY2017	siga	Proceedsfrom Equity Rights Offering Net ProceedsfromEquityRightsOfferingNet	0	USD
CY2017Q4	siga	Receivables Percentage ReceivablesPercentage	1
CY2016	siga	Reducedholdbackamount Reducedholdbackamount	40900000	USD
CY2015	siga	Rent Expense Facilities Lease RentExpenseFacilitiesLease	1400000	USD
CY2016	siga	Rent Expense Facilities Lease RentExpenseFacilitiesLease	1200000	USD
CY2017	siga	Rent Expense Facilities Lease RentExpenseFacilitiesLease	1000000	USD
CY2015	siga	Reorganization Payments ReorganizationPayments	6700000	USD
CY2016	siga	Reorganization Payments ReorganizationPayments	4600000	USD
CY2015	siga	Reorganization Professional Fees ReorganizationProfessionalFees	2027827	USD
CY2016	siga	Reorganization Professional Fees ReorganizationProfessionalFees	1732521	USD
CY2015	siga	Reorganization Trusteefees ReorganizationTrusteefees	59000	USD
CY2016	siga	Reorganization Trusteefees ReorganizationTrusteefees	33000	USD
CY2015	siga	Research And Development Revenue ResearchAndDevelopmentRevenue	8175878	USD
CY2016Q1	siga	Research And Development Revenue ResearchAndDevelopmentRevenue	1270000	USD
CY2016Q2	siga	Research And Development Revenue ResearchAndDevelopmentRevenue	1901000	USD
CY2016Q3	siga	Research And Development Revenue ResearchAndDevelopmentRevenue	4658000	USD
CY2016Q4	siga	Research And Development Revenue ResearchAndDevelopmentRevenue	7159000	USD
CY2016	siga	Research And Development Revenue ResearchAndDevelopmentRevenue	14987628	USD
CY2017Q1	siga	Research And Development Revenue ResearchAndDevelopmentRevenue	5202000	USD
CY2017Q2	siga	Research And Development Revenue ResearchAndDevelopmentRevenue	4265000	USD
CY2017Q3	siga	Research And Development Revenue ResearchAndDevelopmentRevenue	1390000	USD
CY2017Q4	siga	Research And Development Revenue ResearchAndDevelopmentRevenue	1412000	USD
CY2017	siga	Research And Development Revenue ResearchAndDevelopmentRevenue	12268960	USD
CY2017Q4	siga	Researchand Development Future Aggregate Amount ResearchandDevelopmentFutureAggregateAmount	12900000	USD
CY2017	siga	Researchand Development Revenue Longterm Contract ResearchandDevelopmentRevenueLongtermContract	9000000	USD
CY2014	siga	Revenue Percentage RevenuePercentage	1
CY2016	siga	Revenue Percentage RevenuePercentage	1
CY2017	siga	Revenue Percentage RevenuePercentage	1.00
CY2015Q4	siga	Share Based Compensation Arrangement By Share Based Payment Award Options Performance Based Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPerformanceBasedNumber	200000	shares
CY2015	siga	Stock Issuance Fees Expense StockIssuanceFeesExpense	0	USD
CY2016	siga	Stock Issuance Fees Expense StockIssuanceFeesExpense	1764240	USD
CY2017	siga	Stock Issuance Fees Expense StockIssuanceFeesExpense	0	USD
CY2016	siga	Stock Issued During Period Value Backstop Agreement StockIssuedDuringPeriodValueBackstopAgreement	1764240	USD
CY2016	siga	Stock Issued During Period Value Rights Offering StockIssuedDuringPeriodValueRightsOffering	34596469	USD
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2517072	USD
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1328867	USD
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3154370	USD
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1802107	USD
CY2016Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	2357194	USD
CY2017Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	2538340	USD
CY2016Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4584752	USD
CY2017Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5481579	USD
CY2016Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	481641	USD
CY2017Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	381980	USD
CY2016Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	262664	USD
CY2017Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	328588	USD
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3468266	USD
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3346738	USD
CY2016Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	213714154	USD
CY2017Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	214229581	USD
CY2015	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1528582	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	775541	USD
CY2017	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1101031	USD
CY2015	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1600000	USD
CY2016	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	800000	USD
CY2017	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1100000	USD
CY2016Q4	us-gaap	Assets Assets	160981977	USD
CY2017Q4	us-gaap	Assets Assets	144670379	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	69159474	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	37364493	USD
CY2017Q4	us-gaap	Capital Units Authorized CapitalUnitsAuthorized	620000000	shares
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	99713929	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	112711028	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	28701824	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19857833	USD
CY2015	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	12997099	USD
CY2016	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-84009204	USD
CY2017	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-8843991	USD
CY2016Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	2.29
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000	shares
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	79039000	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	79039000	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	78692912	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	78692912	shares
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	7869	USD
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	7904	USD
CY2015	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	439934	USD
CY2016	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-5093	USD
CY2017	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	623060	USD
CY2015	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	440880	USD
CY2016	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-6539	USD
CY2017	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	624239	USD
CY2015	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	946	USD
CY2016	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-1446	USD
CY2017	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1179	USD
CY2015	us-gaap	Debtor Reorganization Items Legal And Advisory Professional Fees DebtorReorganizationItemsLegalAndAdvisoryProfessionalFees	5719052	USD
CY2016	us-gaap	Debtor Reorganization Items Legal And Advisory Professional Fees DebtorReorganizationItemsLegalAndAdvisoryProfessionalFees	1951381	USD
CY2015	us-gaap	Debtor Reorganization Items Other Expense Income DebtorReorganizationItemsOtherExpenseIncome	5672	USD
CY2016	us-gaap	Debtor Reorganization Items Other Expense Income DebtorReorganizationItemsOtherExpenseIncome	0	USD
CY2016Q4	us-gaap	Deferred Costs DeferredCosts	72649277	USD
CY2017Q4	us-gaap	Deferred Costs DeferredCosts	96592334	USD
CY2015	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	19006	USD
CY2016	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	21252	USD
CY2017	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-2724371	USD
CY2015	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	21103	USD
CY2016	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	20423	USD
CY2017	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2718029	USD
CY2016Q4	us-gaap	Deferred Revenue DeferredRevenue	0	USD
CY2017Q4	us-gaap	Deferred Revenue DeferredRevenue	1255318	USD
CY2016Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	367483905	USD
CY2017Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	377641485	USD
CY2015	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	2097	USD
CY2016	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-829	USD
CY2017	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	6342	USD
CY2016Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	102520433	USD
CY2017Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	84130212	USD
CY2016Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	665531	USD
CY2017Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	282213	USD
CY2016Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	182303388	USD
CY2017Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	127800813	USD
CY2017Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	2431963	USD
CY2016Q4	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	0	USD
CY2017Q4	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	2431963	USD
CY2016Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	26838215	USD
CY2017Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	25244156	USD
CY2016Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	72726440	USD
CY2017Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	38087782	USD
CY2016Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1337941	USD
CY2017Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1024082	USD
CY2016Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	667008	USD
CY2017Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	417085	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax	2029190	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax	2652250	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax	2700000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense DeferredTaxAssetsTaxDeferredExpense	669602	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense DeferredTaxAssetsTaxDeferredExpense	205527	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1687243	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1001662	USD
CY2016Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	155465173	USD
CY2017Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	102556657	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	286066	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill	287729	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill	193458	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	286066	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	0	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	982117	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	1100089	USD
CY2015	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	247357	USD
CY2016	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	174275	USD
CY2017	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	132189	USD
CY2015	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.73
CY2016Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.19
CY2016Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.18
CY2016Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.17
CY2016Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.15
CY2016	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.69
CY2017Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.11
CY2017Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.10
CY2017Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.12
CY2017Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.13
CY2017	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.46
CY2015	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.012
CY2016	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000
CY2017	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.055
CY2017Q4	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2017Q4	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2017Q4	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2015	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2016	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2017	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.278
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.301
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.360
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.000
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.000
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.051
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.014
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.002
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.018
CY2015	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.000
CY2016	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.006
CY2017	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.039
CY2017	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	4738753000	USD
CY2016Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	6727409000	USD
CY2017Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	11466162000	USD
CY2016Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	455220	USD
CY2017Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	363588	USD
CY2015	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	0	USD
CY2016	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	0	USD
CY2017Q1	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	0	USD
CY2017Q2	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	0	USD
CY2017Q3	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	-1225000	USD
CY2017Q4	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	0	USD
CY2017	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	-1225421	USD
CY2016Q4	us-gaap	Goodwill Goodwill	898334	USD
CY2017Q4	us-gaap	Goodwill Goodwill	898334	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-38989341	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-39684076	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-38329274	USD
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	461983	USD
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	13884	USD
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2093790	USD
CY2015	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1862779	USD
CY2016	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-177342	USD
CY2017	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1847427	USD
CY2015	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3185098	USD
CY2016	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-522360	USD
CY2017	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1352263	USD
CY2015	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	20075554	USD
CY2016	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	19712849	USD
CY2017	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	23943057	USD
CY2015	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	255176572	USD
CY2016	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	112225534	USD
CY2017	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	11412898	USD
CY2015	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-6597389	USD
CY2016	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	13762876	USD
CY2017	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-22690715	USD
CY2015	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	0	USD
CY2016	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-80928	USD
CY2017	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	60084	USD
CY2015	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-73107	USD
CY2016	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-84228	USD
CY2017	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-203654	USD
CY2015	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-229266	USD
CY2016	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	330443	USD
CY2017	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	1065573	USD
CY2015	us-gaap	Interest Expense InterestExpense	266726	USD
CY2016	us-gaap	Interest Expense InterestExpense	2395517	USD
CY2017	us-gaap	Interest Expense InterestExpense	14758140	USD
CY2016Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	7293880	USD
CY2017Q4	us-gaap	Inventory Net InventoryNet	2983249	USD
CY2016Q4	us-gaap	Inventory Work In Process And Raw Materials InventoryWorkInProcessAndRawMaterials	18916084	USD
CY2016Q2	us-gaap	Litigation Settlement Interest LitigationSettlementInterest	4259000	USD
CY2017Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	957804	USD
CY2016Q4	us-gaap	Inventory Net InventoryNet	26209964	USD
CY2017Q4	us-gaap	Inventory Work In Process And Raw Materials InventoryWorkInProcessAndRawMaterials	2025445	USD
CY2015	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
CY2016	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
CY2017	us-gaap	Inventory Write Down InventoryWriteDown	536000	USD
CY2016Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	2542044	USD
CY2017Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	2420028	USD
CY2016Q4	us-gaap	Liabilities Liabilities	448400246	USD
CY2017Q4	us-gaap	Liabilities Liabilities	467808670	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	160981977	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	144670379	USD
CY2015	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	0	USD
CY2016	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	5832624000000	USD
CY2017	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	0	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7101824	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6810446	USD
CY2015	us-gaap	Liabilities Subject To Compromise Period Increase Decrease LiabilitiesSubjectToCompromisePeriodIncreaseDecrease	-192067797	USD
CY2016	us-gaap	Liabilities Subject To Compromise Period Increase Decrease LiabilitiesSubjectToCompromisePeriodIncreaseDecrease	-160072170	USD
CY2017	us-gaap	Liabilities Subject To Compromise Period Increase Decrease LiabilitiesSubjectToCompromisePeriodIncreaseDecrease	0	USD
CY2015	us-gaap	Litigation Settlement Interest LitigationSettlementInterest	0	USD
CY2016Q1	us-gaap	Litigation Settlement Interest LitigationSettlementInterest	2917000	USD
CY2016Q3	us-gaap	Litigation Settlement Interest LitigationSettlementInterest	3566000	USD
CY2016Q4	us-gaap	Litigation Settlement Interest LitigationSettlementInterest	927000	USD
CY2016	us-gaap	Litigation Settlement Interest LitigationSettlementInterest	11668900	USD
CY2017	us-gaap	Litigation Settlement Interest LitigationSettlementInterest	0	USD
CY2016Q4	us-gaap	Loans Payable LoansPayable	66553053	USD
CY2017Q4	us-gaap	Loans Payable LoansPayable	71050324	USD
CY2015	us-gaap	Loss Contingency Loss In Period LossContingencyLossInPeriod	14407494	USD
CY2016	us-gaap	Loss Contingency Loss In Period LossContingencyLossInPeriod	0	USD
CY2017	us-gaap	Loss Contingency Loss In Period LossContingencyLossInPeriod	0	USD
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2003331	USD
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	30392913	USD
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-585569	USD
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	3891047	USD
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1188664	USD
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-100124	USD
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	11109383	USD
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-115590781	USD
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8158298	USD
CY2015	us-gaap	Net Income Loss NetIncomeLoss	-39451324	USD
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	-10449000	USD
CY2016	us-gaap	Net Income Loss NetIncomeLoss	-39697960	USD
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	-8615000	USD
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	-9244000	USD
CY2016Q4	us-gaap	Net Income Loss NetIncomeLoss	-10439000	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	-9566000	USD
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	-7501000	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	-9816000	USD
CY2017Q4	us-gaap	Net Income Loss NetIncomeLoss	-10303000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	-36235484	USD
CY2015	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	42202	USD
CY2016	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	102324	USD
CY2017	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	16788	USD
CY2015	us-gaap	Notes Reduction NotesReduction	0	USD
CY2016	us-gaap	Notes Reduction NotesReduction	46900000000000	USD
CY2017	us-gaap	Notes Reduction NotesReduction	0	USD
CY2015	us-gaap	Operating Expenses OperatingExpenses	39129144	USD
CY2016	us-gaap	Operating Expenses OperatingExpenses	46002584	USD
CY2017	us-gaap	Operating Expenses OperatingExpenses	31118129	USD
CY2015	us-gaap	Operating Income Loss OperatingIncomeLoss	-30953266	USD
CY2016Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-7059000	USD
CY2016Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-9285000	USD
CY2016Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-8062000	USD
CY2016Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-6609000	USD
CY2016	us-gaap	Operating Income Loss OperatingIncomeLoss	-31014956	USD
CY2017Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-4269000	USD
CY2017Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-4059000	USD
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-5651000	USD
CY2017Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-4871000	USD
CY2017	us-gaap	Operating Income Loss OperatingIncomeLoss	-18849169	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	4021839	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	571705	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	368467	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	349422	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	347259	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	596237	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	1788749	USD
CY2017Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	174300000	USD
CY2016Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1483253	USD
CY2017Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	977353	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	642083	USD
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	702167	USD
CY2016Q4	us-gaap	Other Liabilities OtherLiabilities	247989	USD
CY2017Q4	us-gaap	Other Liabilities OtherLiabilities	840253	USD
CY2015	us-gaap	Other Noncash Expense OtherNoncashExpense	10052	USD
CY2016	us-gaap	Other Noncash Expense OtherNoncashExpense	566779	USD
CY2017	us-gaap	Other Noncash Expense OtherNoncashExpense	4497271	USD
CY2016Q4	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	217000000	USD
CY2015	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-4000000	USD
CY2016	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0	USD
CY2017	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0	USD
CY2015	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2016	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2017	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	84000	USD
CY2015	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2016	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	3775546	USD
CY2017	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2015	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	USD
CY2016	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	428009	USD
CY2017	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	591067	USD
CY2015	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	108953	USD
CY2016	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	23927	USD
CY2017	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	100124	USD
CY2017Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	954426	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2019999	USD
CY2015	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	12200	USD
CY2016	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
CY2017	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	89498	USD
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3767743	USD
CY2017Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3485378	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	299477	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	138640	USD
CY2015	us-gaap	Reorganization Items ReorganizationItems	7811551	USD
CY2016	us-gaap	Reorganization Items ReorganizationItems	3716902	USD
CY2017	us-gaap	Reorganization Items ReorganizationItems	0	USD
CY2015	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	2000000	USD
CY2016	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
CY2017	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
CY2015	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	13130529	USD
CY2016Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2536000	USD
CY2016Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2948000	USD
CY2016Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6069000	USD
CY2016Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8158000	USD
CY2016	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	19710673	USD
CY2017Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6360000	USD
CY2017Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5068000	USD
CY2017Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2471000	USD
CY2017Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2781000	USD
CY2017	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	16679712	USD
CY2017Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	17200000	USD
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	10138890	USD
CY2017Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	10700000	USD
CY2017Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	10701305	USD
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	17333332	USD
CY2017Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	6542448	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-501140292	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-537375776	USD
CY2015	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	10582068	USD
CY2016Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2656000	USD
CY2016Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3739000	USD
CY2016Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2855000	USD
CY2016Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4464000	USD
CY2016	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	13713635	USD
CY2017Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2870000	USD
CY2017Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3058000	USD
CY2017Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3094000	USD
CY2017Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3281000	USD
CY2017	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	12303050	USD
CY2015	us-gaap	Share Based Compensation ShareBasedCompensation	1574038	USD
CY2016	us-gaap	Share Based Compensation ShareBasedCompensation	775541	USD
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	1101031	USD
CY2010Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	2000000	shares
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	4500000	shares
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	8500000	shares
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	-246502477	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	-284428550	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	-287418269	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	-323138291	USD
CY2015Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2017Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2017	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	53000000	USD
CY2016Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	6727409	USD
CY2017Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	11466162	USD
CY2015	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	53777687	shares
CY2016	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	57188503	shares
CY2017	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	78874494	shares
CY2017	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentration of Credit Risk</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has cash in bank accounts that exceed the Federal Deposit Insurance Corporation insured limits. The Company has not experienced any losses on its cash accounts and no allowance has been provided for potential credit losses because management believes that any such losses would be minimal, if any. </font></div></div>
CY2017	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Revision</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:10pt;color:#222222;">In connection with the preparation of the consolidated financial statements for the year ended December 31, 2017, the Company identified that its warrant liability was incorrectly classified as a current liability on the December 31, 2016 balance sheet.   The 2016 balance sheet has been revised to properly classify the warrant liability as a long-term liability.   This revision does not impact the consolidated statement of operations and comprehensive loss, the consolidated statement of cash flows or the consolidated statement of changes in stockholders’ deficiency for the year ended December 31, 2016 and is not considered material to the previously issued consolidated financial statements or the current consolidated financial statements for the year ended December 31, 2017 as a whole.</font><font style="font-family:inherit;font-size:12pt;color:#222222;"> </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></div>
CY2017	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The consolidated financial statements and related disclosures are prepared in conformity with accounting principles generally accepted in the United States of America. Management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and revenue and expenses during the periods reported. The most significant estimates include the variables used in the calculation of fair value of stock-based awards and warrants granted or issued by the Company; reported amounts of revenue; and the realization of deferred tax assets. Estimates and assumptions are reviewed periodically and the effects of revisions are reflected in the financial statements in the period they are determined to be necessary. Actual results could differ from these estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0001010086-18-000003-index-headers.html	Edgar Link	pending
0001010086-18-000003-index.html	Edgar Link	pending
0001010086-18-000003.txt	Edgar Link	pending
0001010086-18-000003-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
siga-201612_chartx28023a02.jpg	Edgar Link	pending
siga-20171231.xml	Edgar Link	completed
siga-20171231.xsd	Edgar Link	pending
siga-20171231x10k.htm	Edgar Link	pending
siga-20171231_cal.xml	Edgar Link	unprocessable
siga-20171231_def.xml	Edgar Link	unprocessable
siga-20171231_lab.xml	Edgar Link	unprocessable
siga-20171231_pre.xml	Edgar Link	unprocessable
siga-exhibit2312017ye.htm	Edgar Link	pending
siga-exhibit3112017ye.htm	Edgar Link	pending
siga-exhibit3122017ye.htm	Edgar Link	pending
siga-exhibit3212017ye.htm	Edgar Link	pending
siga-exhibit3222017ye.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SIGA
SIGA TECHNOLOGIES INC Stock $siga

2017 Form 10-K Financial Statement

#000101008618000003 Filed on March 06, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SIGA SIGA TECHNOLOGIES INC Stock $siga

2017 Form 10-K Financial Statement

#000101008618000003 Filed on March 06, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SIGA
SIGA TECHNOLOGIES INC Stock $siga